ASILX
Price
$16.38
Change
+$0.01 (+0.06%)
Updated
Dec 3 closing price
Net Assets
1.56B
REMIX
Price
$14.63
Change
+$0.07 (+0.48%)
Updated
Dec 3 closing price
Net Assets
728.63M
Interact to see
Advertisement

ASILX vs REMIX

Header iconASILX vs REMIX Comparison
Open Charts ASILX vs REMIXBanner chart's image
AB Select US Long/Short I
Price$16.38
Change+$0.01 (+0.06%)
VolumeN/A
Net Assets1.56B
Standpoint Multi-Asset Investor
Price$14.63
Change+$0.07 (+0.48%)
VolumeN/A
Net Assets728.63M
ASILX vs REMIX Comparison Chart in %
View a ticker or compare two or three
VS
ASILX vs. REMIX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASILX is a Buy and REMIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ASILX has more cash in the bank: 1.56B vs. REMIX (729M). REMIX pays higher dividends than ASILX: REMIX (5.38) vs ASILX (0.66). ASILX was incepted earlier than REMIX: ASILX (13 years) vs REMIX (6 years). ASILX (1.71) and REMIX (1.64) have similar cost to investors . REMIX has a lower initial minimum investment than ASILX: REMIX (2500) vs ASILX (2000000). ASILX annual gain was more profitable for investors over the last year : 0.76 vs. REMIX (0.73). REMIX return over 5 years is better than : 46.37 vs. ASILX (17.71).
ASILXREMIXASILX / REMIX
Total Expense Ratio1.671.51111%
Annual Report Gross Expense Ratio1.711.64104%
Fund Existence13 years6 years-
Gain YTD9.3652.665351%
Front LoadN/AN/A-
Min. Initial Investment2000000250080,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.56B729M214%
Annual Yield % from dividends0.665.3812%
Returns for 1 year0.760.73105%
Returns for 3 years23.8115.54153%
Returns for 5 years17.7146.3738%
Returns for 10 years40.24N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NWPHF9.36N/A
N/A
Newron Pharmaceuticals SPA
EQTL1.25N/A
N/A
Equitech Int'l Corp.
MBGPF0.92N/A
N/A
MOBERG PHARMA AB
ANIOY6.94N/A
N/A
Acerinox S.A.
ASCCF23.60N/A
N/A
Asics Corp.